{"nct_id":"NCT00651664","title":"A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2007-10-22","start_date_type":"ACTUAL","primary_completion_date":"2010-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-04-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}